Obtain Mediare prospective payment system exemption for the Nevada Cancer Institute (no specific legislation)
Support a cancer-specific medical home or accountable care organization demonstration program as established under the "Patient Protection and Affordable Care Act" (Pub.L. 111-48)
Support increased funding for the Centers for Disease Control and Prevention's (CDC) cancer programs as part of the FY2012 Labor-HHS-Education Appropriations bill (No specific bill number). Oppose cuts to the CDC in the FY2011 spending bill (HR 1473)Support funding for the National Institutes of Health (NIH) at $34.7 billion and increased funding for the National Cancer Institute as part of the FY2012 Labor-HHS-Education Appropriations bill (No specific bill number). Oppose cuts to the NIH in the FY2011 spending bill. Sustain funding at FY2010 levles (HR 1473).
HR 1 - Oppose Section 1812 that would set a $400,000 limit on the total cost of competing research project grants awarded by the NIH in FY2011. Oppose Section 1850, which would require that the NIH fund at least 9,000 new competing research grants in FY2011.
Duration: December 21, 2007
to
May 31, 2011
General Issues: Medicare/Medicaid , Budget/Appropriations , Health Issues , Taxation/Internal Revenue Code , Medical/Disease Research/Clinical Labs , Environmental/Superfund , Natural Resources , Tobacco
Spending: about $218,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2007: House of Representatives, U.S. Senate, Centers For Medicare and Medicaid Services (CMS), White House Office, U.S. Senate,
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Camille Bonta Ms
Office of U.S. Senator John Glenn
Camille Bonta
Legislative Correspondent, Senator John Glenn
U.S. Sen. John Glenn, Legislative Correspondent
Legislative Correspondent, Sen. John Glenn
Senator John Glenn, Legislative Correspondent
U.S. Senator John Glenn, Legislative Correspondent
U.S. Senator John Glenn, Legislative Corresponent
Legislative Correspondent - Senator John Glenn
U.S. Sen John Glenn, Legislative Correspondent
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2011
Ms. Camille Bonta terminated an engagement in which they represented Nevada Cancer Institute on July 20, 2011.
Original Filing: 300405943.xml
1st Quarter, 2011
In Q1, Ms. Camille Bonta lobbied for Nevada Cancer Institute , earning $15,000. The report was filed on April 20, 2011.
Original Filing: 300376949.xml
Lobbying Issues
Obtain Mediare prospective payment system exemption for the Nevada Cancer Institute (no specific legislation)
Support a cancer-specific medical home or accountable care organization demonstration program as established under the "Patient Protection and Affordable Care Act" (Pub.L. 111-48)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Support increased funding for the Centers for Disease Control and Prevention's (CDC) cancer programs as part of the FY2012 Labor-HHS-Education Appropriations bill (No specific bill number). Oppose cuts to the CDC in the FY2011 spending bill (HR 1473)Support funding for the National Institutes of Health (NIH) at $34.7 billion and increased funding for the National Cancer Institute as part of the FY2012 Labor-HHS-Education Appropriations bill (No specific bill number). Oppose cuts to the NIH in the FY2011 spending bill. Sustain funding at FY2010 levles (HR 1473).
HR 1 - Oppose Section 1812 that would set a $400,000 limit on the total cost of competing research project grants awarded by the NIH in FY2011. Oppose Section 1850, which would require that the NIH fund at least 9,000 new competing research grants in FY2011.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2010
In Q4, Ms. Camille Bonta lobbied for Nevada Cancer Institute , earning $15,000. The report was filed on Jan. 24, 2011.
Original Filing: 300355784.xml
Lobbying Issues
Obtain Medicare prospective payment system exemption for the Nevada Cancer Institute (no specific legislation).
Support a cancer-specific medical home or accountable care organization demonstration program as established under the "Patient Protection and Affordable Care Act" (Pub.L. 111-148).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2010
In Q3, Ms. Camille Bonta lobbied for Nevada Cancer Institute , earning $15,000. The report was filed on Oct. 25, 2010.
Original Filing: 300330696.xml
Lobbying Issues
S. 3686 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011. Support inclusion of funding for the Nevada Cancer Institute for the purchase of equipment.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
S. 3751, the Stem Cell Therapeutic and Research Reauthorization Act of 2010" - lobbied in support
Lobbying Issues
Obtain Medicare prospective payment system exemption for the Nevada Cancer Institute (no specific legislation)
Support a cancer-specific Accountable Care Organization demonstration program as established under the "Patient Protectiona nd Affordable Care Act" (Pub. L. 111-148).
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office
2nd Quarter, 2010
In Q2, Ms. Camille Bonta lobbied for Nevada Cancer Institute , earning $15,000. The report was filed on July 20, 2010.
Original Filing: 300303754.xml
Lobbying Issues
FY2011 Labor, Health and Human Services, and Education Appropriations bill - funding for the National Institutes of Health, National Cancer Institute, and the Centers for Disease Control and Prevention
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Obtain Medicare prospective payment system exemption for the Nevada Cancer Institute (no specific legislation)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2010
In Q1, Ms. Camille Bonta lobbied for Nevada Cancer Institute , earning $15,000. The report was filed on April 20, 2010.
Original Filing: 300275803.xml
Lobbying Issues
Obtain Medicare prospective payment system exemption for the Nevada Cancer Institute (no specific legislation)
Repeal and reform the formula used to calculate Medicare physician payments (no specific legislation)
H.R. 3590, the "Patient Protection and Affordable Care Act" -- lobbied on the following sections:
Sec. 3135, Modification of Medicare equipment utilization factor for advanced imaging servcies.
Sec. 5501, Expanding access to primary care services and general surgery services. Remove budget neutrality requirement
Sec. 10323, Medicare coverage for individuals exposed to environmental health hazards.
Sec. 3510, Patient navigator program
Sec. 4107, Coverage of comprehensive tobacco cessation services for pregnant women in Medicaid
Sec. 4104, Removal of barriers to preventive services in Medicare
H.R. 3962, the "Affordable Health Care for America Act." -- lobbied on the following sections:
Sec. 1146, Payment for imaging services
Sec. 1712, Tobacco cessation
Sec. 1306, Waiver of deductible for colorectal cancer screening tests regardless of coding, subsequent diagnosis, or ancillary tissue removal
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 3590, the "Patient Protection and Affordable Care Act" -- lobbied on the following sections:
Sec. 10103, Increases patient access to clinical trials and studies, including cancer clinical trials.
Sec. 10413, Young women's breast health awareness and support of young women diagnosed with breast cancer
Sec. 10408, Grants for small businesses to provide comprehensive workplace wellness programsH.R. 3590, the "Patient Protection and Affordable Care Act" -- lobbied on the following sections (cont.):
Sec. 9007, Additional requirements for charitable hospitals
H.R. 3962, the "Affordable Health Care for America Act." -- lobbied on the following sections:
Sec. 1303, Payment incentive for selected primary care services. Remove budget neutrality.
Sec. 112, Wellness program grants
H.R. 1189, the "Colorectal Cancer Prevention, Early Detection and Treatment Act of 2009" - advocated introduction in of companion legislation in the Senate.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2009
In Q4, Ms. Camille Bonta lobbied for Nevada Cancer Institute , earning $5,000. The report was filed on Jan. 19, 2010.
Original Filing: 300236483.xml
Lobbying Issues
- Support expansion of Medicare prospective payment system exemption to include the Nevada Cancer Institute
- S. 1776, "Medicare Physician Fairness Act of 2009"
- H.R. 3961, the Medicare Physician Payment Reform Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
- H.R. 3293, FY 2010 Labor, Health and Human Services and Education Appropriations Bill - Support inclusion of ($400,000-House / $500,000 - Senate) for cancer education and outreach services conducted by the Nevada Cancer Institute.
- H.R. 3326, FY2010 Defense Appropriations Bill - Support inclusion of funding ($2.5 million-House/$2 million Senate) for wound healing and tissue regeneration research and biomarker discovery.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
- Sen. Sherrod Brown Amendment #2871 to H.R. 3590, the Patient Protection and Affordable Care Act, which would require insurers to provide coverage for routine medical services provided in conjuncted with an approved clinical trial or study.
- H.R. 3590, Sec. 7101, "Expanded participation in 340B program."
3rd Quarter, 2009
In Q3, Ms. Camille Bonta lobbied for Nevada Cancer Institute , earning $15,000. The report was filed on Oct. 19, 2009.
Original Filing: 300211138.xml
Lobbying Issues
H.R. 3200, "America's Affordable Health Choices Act of 2009"
- Support expansion of legislation to include Medicare prospective payment system exemption to the Nevada Cancer Institute
- Sec. 1121, "Sustainable growth rate reform" - Support as written H.R. 3200 Continued...
- Sec. 1147, "Payment for imaging services" - Oppose as written. Support modifications in the proposed utilization assumption rates; Support removal of ultrasound from increases in the utilization assumption rate.
- Sec. 1712, "Tobacco Cessation" - Support as written
- Sec. 1306, "Waiver of deductible for colorectal cancer screening tests regardless of coding, subsequent diagnosis, or anciallary tissue removal" - Support as written
- Sec. 1142, "Extension of payment rule for brachytherapy" - Support as written
"America's Health Future Act of 2009" (no Senate bill number)
- Lincoln Amendment #D-15 (Finance Committee Mark Up) - Support amendment which would expand Medicare prospective payment system exemption to the Nevada Cancer Institute and three other cancer centers.
- Lincoln Amendment #D-11(Finance Committee Mark Up) - Support amendment which would remove radiation therapy from the provision increasing the equipment utilization assumption rate
- Grassley Amendment #F-8 (Finance Committee Mark Up) - Oppose amendment which would remove the rebuttable presumption of resonableness for tax-exempt organizations.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 3293, FY 2010 Labor, Health and Human Services and Education Appropriations Bill - Support funding for the National Institutes of Health and the National Cancer Institute; Support inclusion of ($400,000- House / $500,000- Senate) for cancer education and outreach services conducted by the Nevada Cancer Institute.H.R. 3326, FY2010 Defense Appropriations Bill - Support inclusion of funding ($2.5 million - House / $2 million Senate) for wound healing and tissue regeneration research and biomarker discovery.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. - 3200, "America's Affordable Health Choices Act of 2009" - Oppose limiting the value of itemized deductions for charitable contributions for the most affluent Americans. Support investments in prevention and wellness, specifically tax incentives for workplace wellness programs.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2009
In Q2, Ms. Camille Bonta lobbied for Nevada Cancer Institute , earning $15,000. The report was filed on July 28, 2009.
Original Filing: 300195994.xml
Lobbying Issues
HR 3293 - 2010 Labor, Health and Education Appropriation Bill; Support for a $1 billion funding increase for the National Cancer Institute and a $3 billion increase for the National Institutes of Health
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Medicare physician payment; Medicare payment policy for medical imaging services; Medicare hospital prospective papyment system exemption for cancer hospitals. No specific legislation
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Tax incentives for Employer Wellness Programs; Tax Deductions for Charitable Contributions. No specific legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2009
In Q1, Ms. Camille Bonta lobbied for Nevada Cancer Institute , earning $15,000. The report was filed on April 15, 2009.
Original Filing: 300148869.xml
Lobbying Issues
Support for a 20 percent funding increase for the National Cancer Institute for Fiscal Year 2010. No specific bill number.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Access to cancer clinical trials; Incentives for Employer Wellness Programs; Health Reform Trust Fund Financing (oppose change in tax laws for charitable contributions). No specific bill numbers.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Medicare physician payment formula; Stark self-referral laws; and Medicare payment policy for medical imaging. No specific bill numbers.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 1, the American Recovery and Reinvestment Act
Title VIII; Subtitle B Health and Human Services
National Institutes of Health, National Center for Research Resources,
Agency for Healthcare Research and Quality (Comparative Effectiveness Research); Centers for Disease Control and Prevention (Prevention and Wellness Fund)
Title VI - Medicare and Medicaid Health Information Technology; Miscellaneous Medicare Provisions
Subtitle A - Medicare Incentives; Sec.4101 - Incentives for Eligible Professionals
Title XXX - Health Information Technology and Quality
Subtitle D - Privacy; Part I - Improved Privacy Provisions and Security Provisions
Sec. 13406 - Conditions on Certain Contacts as Part of Health Care Operations; (b) Opportunity to Opt out of Fundraising
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2008
In Q4, Ms. Camille Bonta lobbied for Nevada Cancer Institute , earning $15,000. The report was filed on Jan. 16, 2009.
Original Filing: 300124520.xml
Lobbying Issues
H.R. 6791, the "National Cancer Fund Act of 2008"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Lobbied in support for increased funding for medical research funding through the National Institutes of Health as part of 2009 economic stimulus legislation
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Lobbied in support of including the following for inclusion in a 2009 economic stimulus bill: (1) Medicare prospective payment system exemption for a future hospital affiliated with the Nevada Cancer Institute; and (2) increased Medicaid funding to states.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2008
In Q3, Ms. Camille Bonta lobbied for Nevada Cancer Institute , earning $18,000. The report was filed on Oct. 20, 2008.
Original Filing: 300101788.xml
Lobbying Issues
H.R. 3161, the "Childrens Health and Medicare Protection Act of 2007;" Sec. 505 "PPS Exempt Hospitals." Lobbied in support of adding a future cancer hospital affilitated with the Nevada Cancer Institute to the list of Medicare inpatient prospective payment system exempt cancer hospitals.
S. 3101 and H.R. 6331, the "Medicare Improvements for Patients and Physicians Act of 200." Lobbied in support of a positive Medicare payment update for physicians for the remainder of 2008 and 2009. Also lobbied for the inclusion in S. 3101 and H.R. 6331 of the cancer hospital inpatient prospective payment system exemption language.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 1108, the "Family Smoking Prevention and Tobacco Control Act"
S. 2999, the "Access to Cancer Clinical Trials Act of 2008"
H.R. 6791, the "National Cancer Fund Act of 2008"
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 2638, the "Consolidated Security, Disaster Assistance, and Continuing Appropriations Act of 2009." Lobbied in support for increased funding for the National Institute of Health and the Centers for Disease Control and Prevention.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2008
In Q2, Ms. Camille Bonta lobbied for Nevada Cancer Institute , earning $30,000. The report was filed on July 17, 2008.
Original Filing: 300069180.xml
Lobbying Issues
H.R. 3161, the "Childrens Health and Medicare Protection Act of 2007," Sec. 505 "PPS Exempt Hospitals"; Lobbying in support of adding a future cancer hospital affiliated with the Nevada Cancer Institute to the list of Medicare inpatient prospective payment system exempt cancer hospitals.
S. 3101 and H.R. 6331, the "Medicare Improvement for Patients and Physicians Act of 2008." Lobbied in support of positive Medicare payment update for physicians for the remainder of 2008 and 2009. Also lobbied for the inclusion in S. 3101 and H.R. 6331of the cancer hospital inpatient prospective payment system exemption language.
S. 2790 and HR. 1078, the Comprehensive Cancer Care Improvement Act." Communicated support of the bill.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
S. 742, the "Ban Asbestos in America Act of 2007," lobbied in support of Section 4 supporting research for mesothelioma.
Lobbying Issues
H.R. 2642, the "Supplemental Approprations Act of 2008." Lobbied in support of funding for the National Institutes of Health.
FY 2009 Labor, Health and Education Appropriations (no bill numbers). Lobbied in support of increased funding for the National Institutes of Health (6.5 % increase), the National Cancer Institute (9.5% increase), and the Centers for Disease Control and Prevention (43.9% increase).
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Patient Navigator Outreach and Chronic Disease Prevention Act of 2005, P. L. 109-18, Section 340A;
Lobbied in support of increased funding in FY 2009
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2008
In Q1, Ms. Camille Bonta lobbied for Nevada Cancer Institute , earning $30,000. The report was filed on April 17, 2008.
Original Filing: 300041793.xml
Lobbying Issues
S. 758 and H.R. 1311 the "Nevada Cancer Institute Expansion Act."
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 3162 the "Childrens Health and Medicare Protection Act of 2007," Sec. 505 "PPS Exempt Hospitals"; S. 2785, the "Save Medicare Act of 2008," Sec. 2 "Increase in Medicare Physician Payment Update"; Lobbying in support of adding a future cancer hospital affiliated with the Nevada Cancer Institute to the list of Medicare inpatient prospective payment system exempt cancer hospitals; Lobbying in support of preventing cuts on Medicare physician payments in 2008 and 2009.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
S. 579, the "Breast Cancer and Environmental Research Act of 2007."
Lobbying Issues
S. Con Res 70, the "Fiscal Year 2009 Senate Budget Resolution," in support of amendment offered by Sen. Tom Harkin and Sen. Arlen Specter that would increase funding to the National Institutes of Health by $3 billion. Lobby in support of a 10.3 percent increase to the National Institutes of Health for Fiscal Year 2009 and for a 9.5 percent increast to the National Cancer Institute for fiscal year 2009.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2007
Ms. Camille Bonta filed a lobbying registration on Jan. 29, 2008 to represent Nevada Cancer Institute, effective Dec. 21, 2007.
Original Filing: 300006895.xml
Issue(s) they said they’d lobby about: Medical research funding; Medicare Part B physician payment; Medicare IPPS exemption; cancer prevention and awareness; tobacco control; Medicare reimbursement for medical imaging services .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate